1.
Mazdeh M, Afzali S, Jaafari MR. The therapeutic effect of Avonex, Rebif and Betaferon on EDSS and relapse in multiple sclerosis: a comparative study.
Acta Med Iran. 2010; 48(2) : 83
-8
[PubMed]
2.
Etemadifar M,
Mazdeh M,
Torabi HR,
Ghaffarpour M,
Azimian M,
Salami S,
et al.
A report of multiple sclerosis patients treated by CinnoVex in Iran.
Tehran Univ Med Sci. 2010; 68(1) : 30
-6
3.
Weinstock-Guttman B, Bakshi R. Combination therapy for multiple sclerosis: the treatment strategy of the future?
CNS Drugs. 2004; 18(12) : 777
-92
[DOI][PubMed]
4.
Ebers GC. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis.
Lancet. 1998; 352(9139) : 1498
-504
[DOI]
5.
Pozzilli C, Prosperini L, Sbardella E, De Giglio L, Onesti E, Tomassini V. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
Neurol Sci. 2005; 26(4) -8
6.
Olek MJ, Dawson DM. Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. 2004; : 1631
-64
7.
Cottrell DA,
Kremenchutzky M,
Rice GPA,
Koopman WJ,
Hader W,
Baskerville J,
et al.
The natural history of multiple sclerosis: A geographically based study.
Brain. 1999; 122(4) : 625
-39
8.
Kremenchutzky M,
Cottrell D,
Rice G,
Hader W,
Baskerville J,
Koopman W,
et al.
The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
Brain. 1999; 122 ( Pt 10) : 1941
-50
[PubMed]
9.
IFNB Multiple Sclerosis Study Group . Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis I. Clinical results of a multicenter, randomized, double‐blind, placebo-controlled trial.
Neurol. 1993; 43(4) : 655
10.
Jacobs LD,
Cookfair DL,
Rudick RA,
Herndon RM,
Richert JR,
Salazar AM,
et al.
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
Ann Neurol. 1996; 39(3) : 285
-94
[DOI][PubMed]
11.
Claire SR, Mark JT. Merritt's Neurology. 2005; : 958
-60
12.
Etemadifar M, Janghorbani M, Shaygannejad V. Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Acta Neurol Scand. 2006; 113(5) : 283
-7
[DOI][PubMed]
LEAVE A COMMENT HERE: